Cargando…
Metastasis suppression and enhancement of anti-tumour immunity by targeting the FSTL1-DIP2A axis
Autores principales: | Sundaram, Gopinath M., Quah, Shan, Sampath, Prabha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798567/ https://www.ncbi.nlm.nih.gov/pubmed/35117087 http://dx.doi.org/10.21037/tcr.2018.12.25 |
Ejemplares similares
-
EGF hijacks miR-198/FSTL1 wound-healing switch and steers a two-pronged pathway toward metastasis
por: Sundaram, Gopinath M., et al.
Publicado: (2017) -
FSTL1 promotes bone metastasis by causing immune dysfunction
por: Kudo-Saito, Chie
Publicado: (2013) -
FSTL-1: A New Player in the Prevention of Emphysema
por: Vlahos, Ross
Publicado: (2020) -
Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma
por: Nie, Er, et al.
Publicado: (2018) -
A role for Follistatin-like protein 1 (FSTL1) in colorectal cancer
por: Voutsadakis, Ioannis A.
Publicado: (2020)